Logo

HTG Molecular

In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More

News items for the in vitro diagnostics industry for the week of May 8, 2022.

In Brief This Week: Babson Diagnostics, HTG Molecular Diagnostics, Angle, Mainz Biomed, and More

News items for the in vitro diagnostics industry for the week of March 14, 2022.

In Brief This Week: MDxHealth, Co-Diagnostics, HTG Molecular Diagnostics, Immunovia, and More

News items for the in vitro diagnostics industry for the week of Nov. 8, 2021.

HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease

The company said that it saw growing demand for RUO sample processing services and consumables as development activities among its customer base picked up speed.

In Brief This Week: Becton Dickinson, Quidel, Lucid Diagnostics, AnchorDx, and 54gene

News items for the in vitro diagnostics industry for the week of July 19, 2021.

Jun 18, 2021

In Brief This Week: Hologic, NeoGenomics, Natera, Saga Diagnostics, and More

Apr 5, 2021

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

Mar 25, 2021

HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent

Jan 5, 2021

HTG Molecular Preliminary 2020 Revenues Drop 56 Percent

Nov 23, 2020

HTG Molecular Completes 1-For-15 Reverse Stock Split

Nov 11, 2020

HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021

Nov 10, 2020

HTG Molecular Diagnostics Q3 Revenues Drop 67 Percent

Aug 13, 2020

BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute

Aug 12, 2020

HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

Aug 10, 2020

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

Jun 26, 2020

HTG Molecular Inks $10M Secured Credit Agreement

Jun 12, 2020

HTG Molecular Signs Three European Distribution Agreements

May 13, 2020

HTG Molecular Diagnostics Q1 Revenues Drop 31 Percent Due to COVID-19 Global Facility Closures

Mar 25, 2020

HTG Molecular Diagnostics' FY 2019 Revenues Drop 11 Percent

Feb 13, 2020

Following End of Qiagen Deal, HTG Molecular to Focus on CDx Plans and Other Alliances
Premium

Jan 13, 2020

HTG Molecular Expects 11 Percent Drop in 2019 Revenues

Nov 15, 2019

HTG Molecular Diagnostics Files for $20M Stock Offering

Nov 12, 2019

HTG Molecular Diagnostics Revenues Grow 15 Percent; Firm Lowers Full-Year Guidance

Oct 11, 2019

In Brief This Week: Ortho Clinical Diagnostics, Thermo Fisher Scientific, Novigenix, HTG Molecular Diagnostics

Oct 7, 2019

HTG Molecular Warned by Nasdaq of Listing Non-Compliance